About SoniVie
SoniVie is a company based in Rosh Haayin (Israel) founded in 2014 was acquired by Boston Scientific in March 2025.. SoniVie has raised $62.5 million across 2 funding rounds from investors including Boston Scientific, Andera Partners and Supernova Invest. SoniVie offers products and services including TIVUS System. SoniVie operates in a competitive market with competitors including BTG International, Pulnovo Medical, Aria CV, Adient Medical and Crux Biomedical, among others.
- Headquarter Rosh Haayin, Israel
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sonivie Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$62.5 M (USD)
in 2 rounds
-
Latest Funding Round
$60 M (USD), Series C
Jan 09, 2023
-
Investors
Boston Scientific
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Boston Scientific
(Mar 03, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SoniVie
SoniVie offers a comprehensive portfolio of products and services, including TIVUS System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Ultrasound-based system for renal denervation to reduce hypertension.
Unlock access to complete
Leadership Team
3 people
Operations Team
2 people
Finance and Accounting
1 people
Field Team
1 people
Unlock access to complete
Funding Insights of SoniVie
SoniVie has successfully raised a total of $62.5M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $60 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $60.0M
-
First Round
First Round
(02 Nov 2015)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series C - SoniVie | Valuation | Andera Partners | |
| Nov, 2015 | Amount | Series A - SoniVie | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SoniVie
SoniVie has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Andera Partners and Supernova Invest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SoniVie
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SoniVie
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sonivie Comparisons
Competitors of SoniVie
SoniVie operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BTG International, Pulnovo Medical, Aria CV, Adient Medical and Crux Biomedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments.
|
|
| domain | founded_year | HQ Location |
A medical device for pulmonary hypertension treatment is developed.
|
|
| domain | founded_year | HQ Location |
Device for pulmonary hypertension
|
|
| domain | founded_year | HQ Location |
Bioabsorbable medical devices are developed for pulmonary embolism prevention.
|
|
| domain | founded_year | HQ Location |
Retrievable vena cava filters are developed to prevent pulmonary emboli.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sonivie
Frequently Asked Questions about SoniVie
When was SoniVie founded?
SoniVie was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is SoniVie located?
SoniVie is headquartered in Rosh Haayin, Israel. It is registered at Rosh Haayin, Central District, Israel.
Who is the current CEO of SoniVie?
Tomaso Zambelli is the current CEO of SoniVie.
Is SoniVie a funded company?
SoniVie is a funded company, having raised a total of $62.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.5M, raised on Nov 02, 2015.
What does SoniVie do?
SoniVie was founded in 2014 in Rosh Haayin, Israel, within the medical device sector focused on cardiovascular treatments. A therapeutic intra-vascular ultrasound catheter, known as TIVUS, is developed to target nerves in the pulmonary artery associated with disease progression. This device is inserted into the artery to selectively damage relevant nerves while avoiding contact with vessel walls or adjacent tissues, supporting non-invasive interventions for pulmonary hypertension management.
Who are the top competitors of SoniVie?
SoniVie's top competitors include Pulnovo Medical, BTG International and Aria CV.
What products or services does SoniVie offer?
SoniVie offers TIVUS System.
Who are SoniVie's investors?
SoniVie has 6 investors. Key investors include Boston Scientific, Andera Partners, Supernova Invest, Omega Funds, and TechWald Holding.